May 18, 2020 / 12:11 PM / 15 days ago

BRIEF-Cyclo Therapeutics Reports Positive Feedback From EMA On Trial Design For Niemann-Pick Disease Type C

May 18 (Reuters) - Ctd Holdings Inc:

* CYCLO THERAPEUTICS ANNOUNCES POSITIVE FEEDBACK FROM EUROPEAN MEDICINES AGENCY ON ITS PIVOTAL TRIAL DESIGN FOR TRAPPSOL CYCLO FOR NIEMANN-PICK DISEASE TYPE C Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below